Navigation Links
American Society for Microbiology honors Paul D. Bieniasz
Date:3/2/2010

The 2010 American Society for Microbiology (ASM) Eli Lilly and Company Research Award is being presented to Paul D. Bieniasz, Ph.D., Staff Investigator, Aaron Diamond AIDS Research Center, and Associate Professor and Head, Laboratory of Retrovirology, The Rockefeller University, New York, NY, and Investigator, Howard Hughes Medical Institute, for his work on retrovirus biology. This award recognizes fundamental research of unusual merit in microbiology or immunology by an individual on the threshold of his or her career.

Bieniasz received his Ph.D. from the Imperial College of Science, Technology, and Medicine, University of London, UK and completed his postdoctoral fellowship at Duke University, Durham, NC. He was recruited by the Aaron Diamond AIDS Research Center in 1999. His earlier work included the characterization of the TRIM5a restriction system in primate, rodent, and human cells, and its overlap with Cyclophilin A effects on virus replication. He also worked on the so-called L-domains and their interaction with the ESCRT system for enveloped virus budding, as well as the identification of the site and route of virus assembly and release at the cell surface. Bieniasz and colleagues generated a SHIV virus that replicates well in monkeys which is a major breakthrough that will facilitate study of vaccines and drugs in a primate model.

Bienasz's most recent and exciting work is his identification of the gene he calls "tetherin." A newly-identified antiviral molecule, tetherin is expressed on the surface of cells and blocks the release of freshly-assembled viral particles. This is a novel mechanism by which hosts can defend themselves against viruses. It appears that the tetherin protein is an active component of the interferon-induced innate immune response. It was known that the block was antagonized by Vpu. It was Bieniasz's dissection of how the absence of Vpu causes retention of new HIV-1 particles on the surface of interferon treated cells that lead to the discovery of tetherin.

The Eli Lilly and Company Research Award will be presented during the 110th General Meeting of the ASM, May 23-27, 2010 in San Diego, CA. ASM is the world's oldest and largest life science organization and has more than 43,000 members worldwide. ASM's mission is to advance the microbiological sciences and promote the use of scientific knowledge for improved health and economic and environmental well-being.


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ) ... "Global Facial Recognition Market 2016-2020" report ... ) has announced the addition of the ... report to their offering. --> ... announced the addition of the "Global ...
(Date:2/4/2016)... -- The field of Human Microbiome research and ... hubs of the biotechnology industry. While the Human ... human microbiota, have garnered a lot of attention ... has literally exploded in terms of both basic ... on biomedical aspects of research, development, and commercial ...
(Date:2/3/2016)... --> --> Fourth quarter 2015:   ... compared with fourth quarter of 2014. Gross margin was 46% ... Earnings per share increased to SEK 6.39 (loss: 0.49). ... , --> --> January ... (233.6), up 1,142% compared with 2014. Gross margin was 43% ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... -- On Thursday, February 11, 2-1-1 San Diego ... and disaster services, and the Community Information Exchange ... coordination and service delivery for the community to better ... better connect service providers to the information they can ... has handled more than 2.5 million connections ...
(Date:2/5/2016)... 5, 2016 Amarantus BioScience Holdings, ... focused on developing products for Regenerative Medicine, Neurology and ... Disease Designation (RPDD) from the US Food and Drug ... MANF was previously granted orphan drug designation (ODD) by ... Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), ...
(Date:2/5/2016)... Feb. 5, 2016 Australian-US drug discovery and development ... the appointment of a new Chairman, Mr John O,Connor ... effective immediately. James Garner , has also ... and former Acting CEO, Mr Iain Ross , will ... --> James Garner , has also been formally ...
(Date:2/4/2016)... San Francisco, CA (PRWEB) , ... February 04, ... ... future of enterprise talent development and compliance training, today announced an interactive ... on Morf Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course ...
Breaking Biology Technology: